Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Cancer Currents Blog Post on Anal Cancer Screening Features DCEG Researchers

, by Elise Tookmanian, Ph.D.

Gloved hand holding a medical swab

Researchers are studying different approaches for anal cancer screening, including one that allows people to self-collect samples for testing.

The latest Cancer Currents: An NCI Cancer Research Blog post discusses advances in anal cancer screening in the personal context of anal cancer survivor, Daniel G. Garza. It also focuses on the release of consensus guidelines on anal cancer screening, which focused on screening individuals who have an increased risk of the disease, by an international group of experts representing the International Anal Neoplasia Society.

Our researchers conduct cutting-edge research on anal cancer to quantify anal cancer risk, test the efficacy of the HPV vaccine on anal cancer prevention, and evaluate anal cancer screening tests and biomarkers to inform screening guidelines. Three of our experts were featured in the post: Megan Clarke, Ph.D., M.H.S., investigator in the Clinical Genetics Branch, Sarah S. Jackson, Ph.D., M.P.H., investigator, and Cameron B. Haas, Ph.D., M.P.H., postdoctoral fellow, both in the Infections and Immunoepidemiology Branch. 

Read the Cancer Currents: An NCI Cancer Research Blog post titled, "Anal Cancer Advances Open Door to Screening and Prevention."

Email